Kistler-Tiffany Companies’s Chembio diagnostics, Inc. CEMI Stock Holding History

Kistler-Tiffany Companies’s Portfolio CEMI Stock Details CEMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-500	Closed	-$110	–	835
2022 Q4	$110	Hold	500	–	–	﹤0.01%	796
2022 Q3	$0	Hold	500	–	–	﹤0.01%	843
2022 Q2	$0	Hold	500	–	–	﹤0.01%	813
2022 Q1	$0	Hold	500	–	–	﹤0.01%	790
2021 Q4	$1K	Hold	500	–	–	﹤0.01%	724
2021 Q3	$1K	Hold	500	–	–	﹤0.01%	732
2021 Q2	$1K	Hold	500	–	–	﹤0.01%	725
2021 Q1	$2K	Hold	500	–	–	﹤0.01%	620
2020 Q4	$2K	Hold	500	–	–	﹤0.01%	604
2020 Q3	$2K	Hold	500	–	–	﹤0.01%	601
2020 Q2	$2K	Buy	+500	New	+$4.75K	﹤0.01%	565

Other funds holding CEMI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return

Kistler-Tiffany Companies's CEMI Position: Q1 2023 in Review

Kistler-Tiffany Companies sold out of Chembio diagnostics, Inc. (CEMI) in Q1 2023, closing a stake of 500 shares — an estimated $110 sold.

Kistler-Tiffany Companies first reported a position in CEMI in Q2 2020 and held it in 11 quarters. The position peaked at $2K in Q1 2021. 30 funds tracked by Wall St. Rank hold CEMI as of Q1 2023.

Kistler-Tiffany Companies reported no remaining Chembio diagnostics, Inc. position as of Q1 2023 after selling out during the quarter.
Kistler-Tiffany Companies sold 500 Chembio diagnostics, Inc. shares in Q1 2023, an estimated $110.
Kistler-Tiffany Companies first reported a position in Chembio diagnostics, Inc. in Q2 2020 and held it in 11 quarters.
Kistler-Tiffany Companies's Chembio diagnostics, Inc. position peaked at $2K in Q1 2021.
30 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q1 2023.

Based on Kistler-Tiffany Companies's 13F filing for Q1 2023, filed 3 May 2023.